Eliem Therapeutics Inc (ELYM)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert W. Azelby
Employees:
30
23515 NE NOVELTY HILL RD., SUITE B221 #1, REDMOND, WA 98077
16502240857

Eliem Therapeutics, Inc. focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy and depression.

Data derived from most recent annual or quarterly report
Market Cap 85.282 Million Shares Outstanding26.568 Million Avg 30-day Volume 18.457 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.56
Price to Revenue0.0 Debt to Equity0.0 EBITDA-47.11 Million
Price to Book Value0.767 Operating Margin0.0 Enterprise Value-33.154 Million
Current Ratio24.582 EPS Growth0.596 Quick Ratio22.63
1 Yr BETA 0.4819 52-week High/Low 9.51 / 2.21 Profit Margin0.0
Operating Cash Flow Growth-155.8661 Altman Z-Score12.2135 Free Cash Flow to Firm -29.693 Million
Earnings Report2023-05-15
View SEC Filings from ELYM instead.

View recent insider trading info

Eliem Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ELYM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ELYM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2023-03-21 by PIMBLETT EMILY
  • 4: filed on 2023-03-14 by MORISSET VALERIE
  • 4: filed on 2022-11-02 by MORISSET VALERIE
  • 4: filed on 2022-11-02 by AZELBY ROBERT
  • 4: filed on 2022-11-02 by LAVELLE ERIN
  • 4: filed on 2022-11-02 by BUCHER JAMES B
  • 4: filed on 2022-06-01 by TATE SIMON
  • 4: filed on 2022-06-01 by RA CAPITAL HEALTHCARE FUND LP
  • 4: filed on 2022-06-01 by RATCLIFFE LIAM
  • 4: filed on 2022-06-01 by PATTERSON LEONE D

    • Events (8k)

  • 8-K: filed on 2023-03-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-12-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-18:
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    316.4 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PIMBLETT EMILY CHIEF ACCOUNTING OFFICER

    • Officer
    		 0 2023-03-13 1

    MORISSET VALERIE EVP, R&D AND CSO

    • Officer
    		 466,732 2023-03-10 2

    AZELBY ROBERT PRESIDENT & CEO

    • Officer
    • Director
    		 500,000 2022-10-31 1

    BUCHER JAMES B EVP AND GENERAL COUNSEL

    • Officer
    		 95,000 2022-10-31 1

    LAVELLE ERIN COO & CFO

    • Officer
    		 170,000 2022-10-31 1

    PATTERSON LEONE D

    • Director
    		 10,000 2022-05-19 1

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    RA CAPITAL NEXUS FUND, L.P.

    RA CAPITAL NEXUS FUND II, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • Director
    • 10% Owner
    		 10,000 2022-05-19 1

    RATCLIFFE LIAM

    • Director
    		 10,000 2022-05-19 1

    DUNN JUDITH

    • Director
    		 10,000 2022-05-19 1

    ROSENBERG ADAM JOSEPH

    • Director
    		 188,100 2022-05-19 1

    TATE SIMON

    • Director
    		 10,000 2022-05-19 1

    LEVIN ANDREW DAVID

    • Director
    		 10,000 2022-05-19 1

    AI ETI LLC

    ACCESS INDUSTRIES HOLDINGS LLC

    ACCESS INDUSTRIES MANAGEMENT, LLC

    BLAVATNIK LEN

    • 10% Owner
    • AFFILIATE OF 10% OWNERAFFILIATE OF 10% OWNERAFFILIATE OF 10% OWNER
    		 5,009,400 2021-08-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MORISSET VALERIE - Officer EVP, R&D AND CSO

    		2023-03-14 17:04:42 -0400 2023-03-10 M 61,191 $0.00 a 466,732 direct -0.9868 9.2105 15.1316 5 -0.9868 2

    MORISSET VALERIE - Officer EVP, R&D AND CSO

    		2023-03-14 17:04:42 -0400 2023-03-10 M 61,191 d 61,190 direct

    MORISSET VALERIE - Officer EVP, R&D AND CSO

    		2023-03-14 17:04:42 -0400 2023-03-10 M 255,219 $0.00 a 405,541 direct -0.9868 9.2105 15.1316 5 -0.9868 2

    MORISSET VALERIE - Officer EVP, R&D AND CSO

    		2023-03-14 17:04:42 -0400 2023-03-10 M 255,219 d 5,431 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 22:15:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 21:45:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 21:15:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 20:45:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 20:15:04 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 19:45:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 19:15:04 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 18:45:04 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 18:15:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 17:45:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 17:15:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 16:45:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 16:15:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 15:45:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 15:15:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 14:45:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 14:15:03 UTC -10.4766 15.2966 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 13:45:03 UTC -11.1236 15.6936 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 13:15:04 UTC -11.1236 15.6936 20000
    ELIEM THERAPEUTICS INC ELYM 2023-03-24 12:45:03 UTC -11.1236 15.6936 70000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ELYM -200.0 shares, $-716.0 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments